Amyloidosis: Diagnosis

19 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Cardiac amyloidosis remains underrecognized and underdiagnosed—despite its increasing prevalence and significant impact on heart failure outcomes. Its heterogeneous presentation, ranging from heart failure with preserved ejection fraction (HFpEF) to peripheral neuropathy or unexplained LV thickening, can mask the underlying cause and delay intervention.

In this CardioBites+ video, we’ll break down the key clinical clues that should raise suspicion for cardiac amyloidosis. Learn how to identify the red flags in your patients, distinguish between AL and ATTR types, and apply the latest diagnostic approaches including imaging, biomarker assessment, and tissue biopsy. Early detection can dramatically influence treatment strategies and patient prognosis—don’t miss this essential discussion.

Please visit our post-module evaluation survey as well!
Link to survey: https://www.surveymonkey.com/r/8RL5D9K

Visit our website: https://hfsa.org/cardiobitesplus
HFSA LinkedIn: https://www.linkedin.com/company/hfsa/
HFSA Twitter: https://twitter.com/hfsa
HFSA Learning Center: https://learningcenter.hfsa.org/
Join HFSA to enjoy member benefits: https://hfsa.org/membership/membership-benefits-and-categories
Categoria
Cardiology
Commenta per primo questo video.

Prossimo